Missed appointments are an ongoing challenge in healthcare. In additional to the inconvenience to clinicians and clinic administrators, the financial costs are significant. In the UK the NHS estimates that each missed appointment costs the NHS £150 on average, which is $200 USD. Multiple this number by all missed appointments in your service and the […]
We’re counting down to HealthData21, which will bring together Australasia’s digital health innovators shaping our healthcare future with data analytics and genomics. Join the first national, industry-led meeting in genomics and Australia’s only health data focussed conference in Melbourne on 27-28 May. InGeNA members get a special discount – use code INGENAMEMBER to get $50 […]
Following the rapid adoption of a variety of digital solutions during the Covid-19 pandemic, the focus on improving patient experience using digital solutions is increasing. This is a positive sign that digital solutions will remain post the pandemic because the use of these digital solutions is being refined to improve the patient experience rather than […]
The genomics industry has formed a new alliance to strengthen collaboration, coordinate on key issues and realise opportunities for all Australians to benefit from precision healthcare. The Industry Genomics Network Alliance (InGeNA) was launched today with 13 founding member companies in healthcare and life sciences who will collaborate on programs to embed genomics across Australian […]
Our research in 2019, prior to the coronavirus pandemic, highlighted the high level of importance that those working in the genetics industry placed upon interoperability. In this article we explore the growing importance of the interoperability of clinical genetics software. The term interoperability is essentially to ability of separate computer systems being able to share […]
In June 2020 the findings of a 10 year international clinical study, known as CAPP2, were published. The study follows patients with Lynch Syndrome, a genetic condition that leaves them at higher risk of development bowel cancer. The purpose of the study is to determine whether a daily dose of aspirin can be used to […]
In this article we take a closer look at the technology and the practicalities of implementing telemedicine to create a telegenetics service. The Covid-19 pandemic has lead to a surge in demand for telemedicine across the healthcare sector as greater number of people are either unable or unwilling to attend physical clinic appointments. Allysa Ware, the Program […]
The adoption of telemedicine has been slow around the globe, including in genetics. Telemedicine was in early developing in 1992 and some 30 years later it was still regarded as hard to sell to the health sector. Health sector regulations in a number of countries were not compatible with the adoption of telemedicine, including a […]
The clinical genetics community recognise the increasing demand for direct to consumer (DTC) genetic testing. Companies such as 23andMe sell genetic tests, analyse samples that are sent back and provide the results with some analysis. The results of DTCs frequently look for specific variances in genes, as opposed to testing the entire genome. The analysis […]
TrakGene were very proud to provide four education scholarships to the 43rd Annual Scientific Meeting of the Human Genetics Society of Australasia (HGSA) in Wellington, NZ. Our recipients were PhD candidates and students, along with a Genetics Fellow out of Sydney and Melbourne. The HGSA meeting was attended by over 520 delegates and was run […]
English (Australia) 
English (UK) 
Suomi 
Français 
Deutsch 
हिन्दी 
Italiano 
Bahasa Melayu 
Español 
සිංහල 
Cymraeg 
English 
English (Canada)